Peter Caravan Selected Research

Peter Caravan Research Topics

Disease

34	Fibrosis (Cirrhosis) 10/2023 - 01/2007
19	Thrombosis (Thrombus) 01/2022 - 01/2008
14	Neoplasms (Cancer) 05/2024 - 01/2008
11	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 09/2012
9	Inflammation (Inflammations) 10/2023 - 04/2009
7	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2023 - 12/2013
7	Liver Diseases (Liver Disease) 01/2023 - 04/2014
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
4	Idiopathic Pulmonary Fibrosis 11/2023 - 01/2019
4	Atherosclerotic Plaque (Atheroma) 01/2022 - 04/2009
3	Adenocarcinoma 05/2024 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 01/2018
3	Cicatrix (Scar) 07/2023 - 06/2008
3	Infarction (Infarctions) 07/2023 - 11/2011
3	Myocardial Infarction 07/2023 - 06/2008
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 04/2014
3	Chronic Renal Insufficiency 01/2023 - 10/2014
3	Non-alcoholic Fatty Liver Disease 01/2023 - 05/2018
3	Atherosclerosis 01/2022 - 04/2009
2	Fatty Liver 10/2023 - 05/2018
2	Disease Progression 10/2023 - 01/2021
2	Lung Diseases (Lung Disease) 10/2023 - 01/2022
2	Lung Injury 01/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 03/2010
2	Breast Neoplasms (Breast Cancer) 11/2019 - 10/2012
2	Necrosis 11/2011 - 03/2010
2	Nephrogenic Fibrosing Dermopathy 12/2009 - 12/2009
1	Post-Acute COVID-19 Syndrome 01/2024
1	Chemical and Drug Induced Liver Injury 10/2023
1	Ischemia 01/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Hyperphosphatemia 01/2023
1	Cholestasis 09/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Multiple Sclerosis 01/2022
1	Rupture 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022

Drug/Important Bio-Agent (IBA)

24	CollagenIBA 11/2023 - 01/2007
21	Contrast MediaIBA 01/2023 - 01/2007
17	FibrinIBA 01/2022 - 01/2008
16	GadoliniumIBA 01/2023 - 05/2008
13	Collagen Type I (Type I Collagen)IBA 01/2023 - 09/2012
10	Peptides (Polypeptides)IBA 11/2023 - 03/2012
7	allysineIBA 05/2024 - 01/2017
7	Hydroxyproline (4 Hydroxyproline)IBA 10/2023 - 09/2012
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2008
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 03/2010
6	EP-2104RIBA 01/2020 - 05/2008
5	Bleomycin (Blenoxane)FDA LinkGeneric 11/2023 - 12/2013
5	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023 - 09/2012
5	Gadolinium DTPA (Magnevist)FDA Link 10/2012 - 06/2008
4	Choline (Choline Chloride)IBA 10/2023 - 01/2021
4	Amino Acids FDA Link 10/2023 - 01/2021
4	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020 - 09/2012
3	folfirinoxIBA 05/2024 - 01/2018
3	AldehydesIBA 10/2023 - 01/2022
3	ManganeseIBA 01/2023 - 10/2018
3	streptococcal polysaccharide type III group BIBA 01/2023 - 01/2018
3	Peroxidase (Myeloperoxidase)IBA 01/2022 - 01/2018
2	ferric oxide (iron oxide)IBA 01/2023 - 11/2020
2	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2022
2	gadolinium ethoxybenzyl DTPA FDA Link 01/2023 - 11/2019
2	Phosphates (Orthophosphate)IBA 01/2023 - 04/2016
2	Molecular Probes (Molecular Probe)IBA 09/2022 - 01/2019
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022 - 10/2019
2	Extracellular Matrix ProteinsIBA 01/2022 - 09/2012
2	Radioisotopes (Radionuclides)IBA 01/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 07/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2014
2	EP3533IBA 01/2021 - 01/2019
2	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 01/2020 - 11/2019
2	EDP-305IBA 01/2019 - 07/2018
2	IntegrinsIBA 01/2018 - 05/2017
2	gadofosveset trisodium (MS 325)FDA Link 01/2018 - 05/2010
2	Liposomes (Liposome)IBA 01/2017 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 01/2016
2	ferric chlorideIBA 10/2015 - 07/2015
1	N-acetyltalosaminuronic acid (NAT)IBA 05/2024
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2023
1	deoxypyridinolineIBA 07/2023
1	pyridinolineIBA 07/2023
1	EnzymesIBA 01/2023
1	NAD (NADH)IBA 01/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	PeroxidasinIBA 01/2022
1	5'- O- (9- phenylxanthen- 9- yl)- 2'- deoxynebularineIBA 01/2022
1	CholesterolIBA 01/2022
1	MethemoglobinIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Versicans (Versican)IBA 01/2022

Therapy/Procedure

17	Therapeutics 10/2023 - 03/2010
4	Drug Therapy (Chemotherapy) 05/2024 - 01/2017
2	Neoadjuvant Therapy 05/2024 - 01/2020
2	Ligation 09/2015 - 04/2014
1	Intraperitoneal Injections 10/2023
1	Intravenous Injections 01/2023
1	Carotid Endarterectomy 01/2022